MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Gait ataxia and Autonomic dysfunction as early signs of Creutzfeldt-Jakob Disease: A Case Report

    S. Zaheer, E. Urrea-Mendoza, V. Veerappan (Greenville, USA)

    Objective: To highlight unusual early presenting symptoms of Sporadic Creutzfeldt-Jakob Disease (sCJD). Background: Prion diseases, a group of rare and fatal diseases caused by an…
  • 2022 International Congress

    The clinical challenge of an unilateral abnormal uptake in datscan

    C. Silva, F. Barros, F. Matias, CM. Machado, FM. Moreira, M. Cunha, A. Morgadinho (Coimbra, Portugal)

    Objective: Characterize patients with unilateral abnormal uptake in DaTscan. Background: Presynaptic dopamine transporter (DaT) single-photon emission computed tomography (SPECT) imaging is the most used imaging…
  • 2022 International Congress

    Striatal Subregion Analysis Associated with REM Sleep Behavior Disorder in Parkinson’s disease

    IH. Kwak, HI. Ma, YE. Kim, YJ. Kim (Anyang, Republic of Korea)

    Objective: Herein we evaluated the regional selectivity of presynaptic striatal dopaminergic denervation associated with RBD in drug-naive early PD. Background: REM sleep behavior disorder (RBD)…
  • 2022 International Congress

    Pharmacological activation of Rev-erbα Provides Neuroprotection against Parkinson’s Disease

    L. Kou (Wuhan, China)

    Objective: In this study, we investigated the effects of SR9009, a Rev-ERB agonist, on the dopaminergic system in the MPTP model of PD. Background: Circadian…
  • 2022 International Congress

    Impact of SARS-CoV-2 vaccine in Parkinson’s disease

    E. Reséndiz-Henríquez, E. Ichikawa-Escamilla, P. Bazán-Rodríguez, MA. Ruiz-Mafud, AJ. Hernández-Medrano, GI. Cerda-Hernández, RA. Abundes-Corona, A. Cervantes-Arriaga, M. Rodríguez-Violante (Mexico City, Mexico)

    Objective: To evaluate the impact of SARS-CoV-2 vaccine on motor and non-motor symptoms in Mexican people with Parkinson's disease (PwP). Background: Nowadays, as a consequence…
  • 2022 International Congress

    Brain structure alternations and disrupted functional connectivity in paroxysmal kinesigenic dyskinesia

    Y. Liu, C. Chen, P. Wang, Y. Chen, C. Lin, S. Kwan, C. Chou, D. Yen, Y. Wu (北投區, Taiwan)

    Objective: This study aimed to delineate the morphological and functional alterations of paroxysmal kinesigenic dyskinesia (PKD) by functional magnetic resonance imaging (fMRI). Background: PKD is…
  • 2022 International Congress

    Environmental exposures and clinical phenotype in a sample of patients with Parkinson’s disease in the southwestern Colombian region: preliminary results

    J. Orozco Velez, H. Clavijo-Moran, D. álvarez-García, I. F Mata, B. Muñoz-Ospina (Cali, Colombia)

    Objective: Describe the clinical phenotype and environmental agents of patients from the Colombian southwestern region with familiar and sporadic Parkinson’s disease in a sample Background:…
  • 2022 International Congress

    Factors that negatively impact the sexual function of men living with Parkinson’s disease

    B. de Souza (São Paulo, Brazil)

    Objective: To investigate the impact of motor, non-motor function, and relationship quality on sexual function in men living with PD. Background: Among the non-motor alteration…
  • 2022 International Congress

    LRRK2 Inhibition by BIIB122: Trial designs for two efficacy and safety studies in Parkinson’s disease patients with and without LRRK2 mutations (Lighthouse and Luma)

    J. Shirvan, D. Jennings, P. Wang, R. Maciuca, S. Sahu, F. Sedarati, A. Kay, K. Fraser, S. Huntwork-Rodriguez, M. Yang, M. Levee, P. Chin, T. Dam (Cambridge, USA)

    Objective: Describe Luma and Lighthouse, two studies that investigate efficacy and safety of BIIB122, a LRRK2 inhibitor. Background: Increased LRRK2 kinase activity has been linked…
  • 2022 International Congress

    Role of surface EMG analysis in distinguishing clonic seizures from tremors

    H. Ticku, N. Fotedar (Cleveland, USA)

    Objective: To compare surface EMG characteristics of clonic seizures with tremors. Background: Clonic seizures can clinically mimic tremors. In cases with poor or no EEG…
  • « Previous Page
  • 1
  • …
  • 691
  • 692
  • 693
  • 694
  • 695
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley